Disease Team and New Ideas 2018-2019 grant competition launching June 1, 2017.
KEY DATES FOR DISEASE TEAMS AND NEW IDEAS GRANTS
- June 1, 2017: Grant competition opens
- June 30, 2017: Notice of Intent due
- October 27, 2017: Full grant application due
- November – December 2017: Review process
- February 2018: Funding announcement
- April 1, 2018: Funds are released
The Ontario Institute for Regenerative Medicine has two grant programs to support research related to the application of stem cells to regenerative medicine and improved health outcomes.
DISEASE TEAM GRANTS
This grant competition is based on a 12-month funding period and is up to $750,000 CDN in value, with possible renewed funding.
The Disease Team grant will support projects that are developing novel cellular or stem cell-related therapeutic approaches to tissue repair and regeneration for specific diseases. Projects may also involve:
- Completion of proof-of-principle experiments in small or large animal models using novel cells or compounds/drugs or using novel translational approaches;
- Identification/characterization of compounds/drugs that target stem cell differentiation/proliferation with the aim to develop novel therapeutic approaches;
- Production of reagents necessary for the completion of a clinical trial.
NEW IDEA GRANTS
The New Ideas Grants, are up to $75,000 CDN in value for a 12-month period.
The New Ideas Grant will support projects at the discovery level in the area of stem cell and regenerative medicine research with a goal to foster cutting-edge research in stem cell biology and/or technology. The project can target:
- Basic molecular and cellular mechanisms underlying stem cell properties and behaviours;
- Stem cell or reprogrammed cell-based in vitro models to gain insight into disease mechanisms; or
- Stem cell or reprogrammed cell studies leading to novel therapies.
Applications Deadline: Wednesday, April 26, 2017 (12:00 pm EST)
Our “Stem Cells in 60 Seconds” presentation will allow 10 lucky participants to present their work at the OIRM Annual Symposium on May 25th 2017. Participants will be allowed a single PowerPoint slide and 60 sec to describe their research to the audience. This pitch is a great opportunity for you to showcase your research to the OIRM community. Be creative and tell us your science story, but keep an eye on the clock, 60 sec is not long!
This competition is limited to 10 participants; all interested participants must submit an application form. Selected participants will be informed of their successful application.
To apply download the Application Form.
For any questions please contact firstname.lastname@example.org
Congratulations to the following trainees:
- Kelsey Adams, Cindi Morsehead lab
- Brian Ballios, Derek van der Kooy lab
- Alejandro Gomez-Aristizabal, Sowmya Viswanathan lab
- Kenneth Grise, Derek van der Kooy lab
- Miriel Ho, Duncan Stewart lab
- Qin Liang, Andras Nagy lab
- Mina Ogawa, Gordan Keller lab
- Fares Ould-Brahim, Jing Wang lab
- Gurdeep Singh, Jennifer Mitchell lab
- Anges Soos, Craig Simmons lab
Postdoctoral Fellowship Award - OIRM & Medicine by Design (MbD)
APPLICATION ARE NOW CLOSED
- Up to two postdoctoral positions are available for the 2017 competition
- Each award will receive up to $50,000 CDN per year for up to three years
- The host PI will supplement funds to cover travel costs and health benefits
- Training opportunities available with over 160 research programs across the province (OIRM) and the MbD community at the University of Toronto
- Opportunity to present your work at the OIRM Annual Symposium, the Till & McCulloch Meetings, and MbD events.
- Translational and commercialization experience through the activities of the Centre for Commercialization of Regenerative Medicine in Toronto
- Canada has one of the highest quality of life rankings in the world including exceptional health care, education and standard of living
Instructions: Guidelines Form
To Apply: Application Form
2016 Postdoctoral Fellowship Awardees
- Jeffrey Harding, Nagy Lab, Lunenfeld-Tanenbaum Research Institute - Local ON/OFF control of tolerance toward allograft cell transplants
- Vladimir Manchev, Keller Lab, McEwen Centre for Regenerative Medicine - Dissecting the role of Notch signaling during the transition of HE to HSC.